Cargando…
Oncology pharmacists’ response to COVID-19 pandemic in Jordan: The King Hussein Cancer Center experience
Autores principales: | Al-Rabayah, Abeer A, Hammoudeh, Suzan S, AbuBlan, Rasha S, Najjar, Rula, Salmany, Sewar S, Nassar, Noor, Nazer, Lama, Jaddoua, Saad M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8005308/ https://www.ncbi.nlm.nih.gov/pubmed/33828833 http://dx.doi.org/10.7189/jogh.11.03048 |
Ejemplares similares
-
Will Jordan be closer to UHC after the COVID-19 pandemic?
por: Al-Ajlouni, Reem, et al.
Publicado: (2020) -
Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021) -
Stage I seminoma: treatment outcome at King Hussein Cancer Center in Jordan
por: Khader, Jamal, et al.
Publicado: (2012) -
Pulmonary Alveolar Microlithiasis: a Case Report in King Hussein Medical Center (KHMC), Amman, Jordan
por: Haddad, Rakan M., et al.
Publicado: (2020) -
The burden and scope of childhood cancer in displaced patients in Jordan: The King Hussein Cancer Center and Foundation Experience
por: Rihani, Rawad, et al.
Publicado: (2023)